Megaloblastic Anaemia

Postgraduate Haematology: Fifth Edition

Volumn , Issue , 2007, Pages 60-84

  Hoffbrand, A Victor ^a   Green, Ralph ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular disease; Cobalamin folate relationship; Megaloblastic anaemia; Neural tube defects; Peripheral blood

Indexed keywords

EID: 84890651015     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987056.ch5     Document Type: Chapter

References (43)

1. Blount BC, Mack NM, Wehr CM et al. (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proceedings of the National Academy of Sciences of the USA 94:3290-5.
2. Boros LG, Steinkamp MP, Fleming JC et al. (2003) Defective RNA ribose synthesis in fibroblasts from patients with thiamineresponsive megaloblastic anemia (TRMA) Blood 102: 3556-61.
3. Carmel R (1995) Malabsorption of food cobalamin. Baillière's Clinical Haematology 8: 639-55.
4. Chanarin I, Metz J (1997) Diagnosis of cobalamin deficiency: the old and the new. British Journal of Haematology 97: 695-700.
5. Christensen EI, Birn H (2002) Megalin and cubilin: Multifunctional endocytic receptors. National Review of Molecular and Cellular Biology 3: 258-68A.
6. Clarke R, Smith AD, Jobst KA et al. (1998) Folate, vitamin B12 and serum total homocysteine levels in confirmed Alzheimer's disease. Archives of Neurology 55: 1449-55.
7. Creizel AE, Dudas I (1992) Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation. New England Journal of Medicine 327: 1832-5.
8. D'Angelo A, Selhub J (1997) Homocysteine and thrombotic disease. Blood 90: 1-11.
9. Delpre G, Stark P, Niv Y (1999) Sublingual therapy for cobalamin deficiency as an alternative to oral and parenteral cobalamin supplementation. Lancet 354: 740-1.
10. Frosst P, Blom HJ, Milos R et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 10: 111-13.
11. Fyfe JC, Madsen M, Hojrup P et al. (2004) The functional cobalamin (vitamin B12) intrinsic factor receptor is a novel complex of cubulin and aminonless. Blood 103: 1573-9.
12. Giovannucci E, Stamfer MJ, Colditz GA et al. (1998) Multivitamin use, folate and colon cancer in women in the Nurses Health Study. Annals of Internal Medicine 129: 517-24.
13. Green R (1995) Metabolite assays in cobalamin and folate deficiency. Baillière's Clinical Haematology 8: 533-66.
14. Green R, Miller JW (1999) Folate deficiency beyond megaloblastic anemia: hyperhomocysteinemia and other manifestations of dysfunctional folate status. Seminars in Hematology 36: 47-64.
15. He K, Anwar M, Rimm E et al. (2004) Folate, vitamin B6 and B12 intakes in relation to risk of stroke among men. Stroke 35: 169-74.
16. Healton EB, Savage DG, Brust JC et al. (1991) Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 70: 229-245.
17. Herzlich B, Herbert V (1988) Depletion of serum holotranscobalamin II An early sign of negative vitamin B12 balance. Laboratory Investigations 58: 332-7.
18. Koury MJ, Horne DW, Brown ZA et al. (1997) Apoptosis of latestage erythroblasts in megaloblastic anemia: association with DNA damage and macrocyte production. Blood 89: 4617-23.
19. Kozyraki R, Kristiansen M, Silahtraroglu A et al. (1998) The human intrinsic-factor-vitamin B12 receptor: molecular characterization and chromosomal mapping of the gene to 10p within the autosomal megaloblastic anemia (MAI) region. Blood 91: 3593-600.
20. Lincz L, Scorgie FE, Kerridge I et al. (2003) Methionine synthase genetic polymorphs in MSA27569 alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma. British Journal of Haematology 120: 1051-4.
21. Lucock M (2004) Is folic acid the ultimate functional food component for disease prevention. British Medical Journal 328:211-14.
22. Miller JW, Ramos MI, Garrod MG et al. (2002) Transcobalamin II 775G> C polymorphism and indices of vitamin B12 status in healthy older adults. Blood 100: 718-20.
23. Mills JL, McPartlin JM, Kirke PN et al. (1995) Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 345: 149-51.
24. Mills JL, VonKohirin I, Conley MR et al. (2003) Low vitamin B12 concentrations in patients without anemia: the effect of folic acid fortification of grain. American Journal of Clinical Nutrition 77:1474-7.
25. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131-7.
26. Rosenblatt DS, Whitehead VM (1999) Cobalamin and folate deficiency:acquired and hereditary disorders in children. Seminars in Hematology 36: 19-34.
27. Rothenberg SP, daCosta MP, Sequeira JM et al. (2004) Autoantibodies against folate receptors in women with a pregnancy complicated by a neural tube defect. New England Journal of Medicine 350: 134-42.
28. Savage DG, Lindebaum, J (1995) Neurological complications of acquired cobalamin deficiency: clinical aspects. Clinical Haematology 8: 657-78.
29. Schnyder G, Roffi M, Pin R et al. (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. New England Journal of Medicine 345: 1593-1600.
30. Seshadri S, Beiser A, Selhub J et al. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine 346: 476-83.
31. Shaw GM, Lammer EJ, Wasserman CR et al. (1995) Risks of facial clefts in children born to women using multi-vitamins containing folic acid periconceptually. Lancet 346: 393-6.
32. Skibola CF, Smith MT, Kane E et al. (1999) Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukaemia in adults. Proceedings of the National Academy of Sciences of the USA 62: 1044-51.
33. Solomon LR (2005) Cobalamin-responsive disorders in the ambulatory case setting: unreliability of cobalamin, methylmalonic acid and homocysteine testing. Blood (in press).
34. Stopack A (2000) Links between Helicobacter pylori infection, cobalamin deficiency and pernicius anemia. Archives of Internal Medicine 160: 1229-30.
35. Tanner SM, Aminoff M, Wright FA et al. (2003) Amnionless, essential for mouse gastrulation, is mutated in recessive hereditary megaloblastic anemia. Nature Genetics 33: 426-9.
36. Toh M-H, Van Driel IR, Gleeson PA (1997) Pernicious anemia. New England Journal of Medicine 337: 1441-8.
37. Van der Put MMJ, Steegers-Theunissen PM, Frosst P et al. (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346: 1070-1.
38. Wald DS, Low M, Morris JK (2002) Homocysteine and cardiovascular disease: evidence of causality from a meta-analysis. British Medical Journal 325: 1202-6.
39. Ward M, McNulty H, McPartlin J et al. (1997) Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological amounts of folic acid. Quarterly Journal of Medicine 90:1-6.
40. Weir DG, Scott JM (1995) The biochemical basis of the neuropathy in cobalamin deficiency. Clinical Haematology 8: 479-98.
41. Welch GN, Loscalzo J (1998) Homocysteine and artherothrombosis. New England Journal of Medicine 338: 1042-50.
42. Wickramasinghe SN (ed.) (1995) Megaloblastic anaemia. Clinical Haematology 8: 441-703.
43. Wickramasinghe SN (1995) Morphology, biology and biochemistry of cobalamin and folate deficient bone marrow cells. Clinical Haematology 8: 441-59.